IRCT20210901052358N4 IRCT 2022-04-13 Shahid Beheshti University of Medical Sciences Efficacy of Ivermectin in the treatment of COVID-19 Evaluating the Efficacy of Ivermectin in the Treatment of COVID-19 Patients 2022-04-30 anticipated 60 Complete https://irct.ir/trial/62832 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method is a simple randomization that is done in the form of individual random units. The tool used to do this is a random numbers table. The method of constructing a random sequence is that first the researcher selects one of the numbers with his eyes closed and then moves in the right direction. Odd numbers are considered for intervention and even numbers are for control. Random concealment is also performed using sequentially numbered sealed opaque envelopes (SNOSE). N/A COVID-19. Intervention 1: Intervention group: Group A, in addition to standard treatment, receives oral ivermectin 200 micrograms per kilogram of body weight for the first and third days of treatment. Standard treatments include serum therapy, vitamins, supplemental oxygen, and remdesivir (200 mg intravenously for first day and 100 mg daily intravenously for the next 4 days). Intervention 2: Intervention group: Group B, in addition to standard treatment, receives oral ivermectin 200 micrograms per kilogram of body weight for the first, third, and fifth days of treatment. Standard treatments include serum therapy, vitamins, supplemental oxygen, and remdesivir (200 mg intravenously for first day and 100 mg daily intravenously for the next 4 days). Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.